Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Golnaz Khakpour"'
Autor:
Golnaz Khakpour, Mehrdad Noruzinia, Pantea Izadi, Fatemeh Karami, Mohammad Ahmadvand, Ramin Heshmat, Mahsa M Amoli, Javad Tavakkoly-Bazzaz
Publikováno v:
Tumor Biology, Vol 39 (2017)
Critical roles of epigenomic alterations in the pathogenesis of breast cancer have recently seized great attentions toward finding epimarkers in either non-invasive or semi-non-invasive samples as well as peripheral blood. In this way, methylated DNA
Externí odkaz:
https://doaj.org/article/a77c3ebb644e4f849dea710aa8e906e7
Autor:
Masood Naseripour, Fatemeh Azimi, Said Talebi, Reza Mirshahi, Reza Kiaee, Ahad Sedaghat, Ataei Kachoei Zohre, Golnaz Khakpour
Publikováno v:
Ophthalmic Genetics. 44:211-217
Publikováno v:
Molecular Genetics and Genomics. 297:1615-1626
Retinal capillary hemangioblastomas (RCH) is a benign tumor that represents the initial manifestation in roughly half of Von Hippel Lindau (VHL) patients. They may also occur sporadically without systemic involvement. A first meta-analysis study was
Autor:
Sara Hemmati, Golnaz Khakpour, Fatemeh Nadjafi-Semnani, Arzhang Gordiz, Masoome Sajadi, Fatemeh Abdi
Publikováno v:
Ophthalmic Genetics. 43:140-142
Autor:
Javad Tavakkoly-Bazzaz, Mohamad Ahmadvand, Mehrdad Noruzinia, Golnaz Khakpour, Ali Dehghanifard, Fatemeh Azimi
Publikováno v:
Asian Pacific Journal of Cancer Prevention : APJCP
Introduction: Breast cancer is a highly diverse disease, and epigenomic alterations, as principle changes in the pathogenesis of breast cancer, have recently been noticed in epimarker research on peripheral blood. Methods: In this study, DNA samples
Identification of MiR-125a as a Novel Plasma Diagnostic Biomarker for Chronic Lymphoblastic Leukemia
Autor:
Mostafa Montazer-Zohour, Mohammad Ahmadvand, Saba Manoochehrabadi, Golnaz Khakpour, Anoosh Naghavi, Marjan Yaghmaie, Hossein Pashaiefar, Mahsa Eskandari
Publikováno v:
Clinical Laboratory. 65
iBackground:/iChronic lymphocytic leukemia (CLL) is a type of malignancy in which the bone marrow makes too many lymphocytes. MicroRNAs (miRNAs) are endogenous short (~22-nucleotides) non-protein-coding regulatory RNA molecules with key roles in cell
Autor:
Marjan Yaghmaie, Saba Manoochehrabadi, Golnaz Khakpour, Mostafa Montazer Zohour, Hossein Pashaiefar, Mahsa Eskandari, Fatemeh Sheikhsaran, Mohammad Ahmadvand
Publikováno v:
Leukemia research. 70
The expression patterns of microRNAs in plasma are involved in potential biomarkers for several diseases. The goal of this study was to explore the expression level of miR-155 in diffuse large B-cell lymphoma (DLBCL) and its clinical significance.We
Autor:
Azadeh, Shojaei, Reza, Ebrahimzadeh-Vesal, Ali, Ahani, Maryam, Razzaghy-Azar, Golnaz, Khakpour, Farideh, Ghazi, Javad, Tavakkoly-Bazzaz
Publikováno v:
Reports of biochemistrymolecular biology. 6(1)
Disorders of sex development (DSDs) belong to uncommon pathologies and result from abnormalities during gonadal determination and differentiation. Various gene mutations involved in gonadal determination and differentiation have been associated with
Publikováno v:
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine. 36(7)
Breast cancer is the most common malignancy among women worldwide. Risk assessment is one of the main services delivered by cancer clinics. Biomarker analysis on different tissues including the peripheral blood can provide crucial information. One of